Company Number: 13127137

Analysis Date: 2025-07-20 13:57 UTC

Financial Health Assessment Report for BEARD SURGEON LTD

---

1. Financial Health Score: B

Explanation:
BEARD SURGEON LTD demonstrates solid financial improvements with a strong balance sheet, especially notable for a micro-entity incorporated only in 2021. The company shows significant growth in net assets and working capital, indicating a healthy liquidity position and asset base. However, some caution is warranted due to the micro-entity status and limited financial disclosure detail, which restricts deeper profitability or cash flow analysis.

---

2. Key Vital Signs

Metric	2024 (£)	Interpretation
Fixed Assets	46,160	Indicates investment in long-term resources; healthy for a small wholesale business.
Current Assets	50,945	Available liquid resources and receivables; substantially increased from previous year.
Prepayments and Accrued Income	500,000	Large prepayments suggest advanced payments or deferred income; requires monitoring for timing.
Current Liabilities	22,724	Obligations due within a year; manageable relative to current assets.
Net Current Assets (Working Capital)	528,221	Excellent liquidity cushion; company can comfortably meet short-term obligations.
Net Assets (Equity)	582,381	Strong equity base, reflecting retained earnings or capital injections; signals financial stability.
Share Capital	8,000	Modest initial capital; growth mostly driven by retained profits or asset revaluation.
Average Number of Employees	3	Small team, appropriate for micro-entity classification and current scale.

Interpretation of Vital Signs:
The company’s working capital is like a healthy blood flow in the business — more than sufficient to keep daily operations running smoothly. The strong net asset base resembles good bone density, providing structural support to the company’s financial health. However, the very large prepayments and accrued income (£500,000) represent an unusual symptom that should be examined closely to ensure it does not mask timing mismatches or risks.

---

3. Diagnosis

BEARD SURGEON LTD is displaying robust financial health for a young micro-entity in the wholesale perfume and cosmetics sector. The significant increase in net assets and working capital over recent periods suggests successful business development and asset accumulation. The three directors hold equal significant control, which can promote aligned strategic decision-making but requires careful governance to avoid conflicts.

The large prepayments or accrued income could indicate advance payments made to suppliers or customers, or deferred income from contracts; this is not inherently negative but calls for monitoring to avoid liquidity strain or revenue recognition issues in future periods.

No signs of distress such as overdue filings, negative net assets, or excessive liabilities are observed. The company’s financial “vital signs” suggest it is in a healthy condition with strong liquidity, good asset management, and stable equity.

---

4. Recommendations

• Review Prepayments and Accrued Income: Investigate the nature and timing of the £500,000 prepayments/accrued income to ensure these balances are realized promptly and reflect genuine business activity rather than timing mismatches or uncollectible items.

• Maintain Strong Cash Flow Monitoring: Although working capital is currently very healthy, continuous monitoring of cash inflows and outflows will help detect any early symptoms of cash flow issues, especially as the company grows.

• Governance and Control: With three directors holding equal control, implement clear governance policies and regular board meetings to ensure aligned decision-making and mitigate risks from potential conflicts.

• Growth and Investment Strategy: Consider prudent reinvestment of profits into marketing, product development, or operational capacity to capitalize on market opportunities in the grooming and cosmetics wholesale sector.

• Prepare for Scaling: As the company grows beyond micro-entity thresholds, prepare for more comprehensive financial reporting and possible audit requirements to maintain transparency and investor confidence.

---